Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate
Protein kinase C family consists of 11 isoforms, classified into 3 categories according to their structure and mechanisms of activation. These isoenzymes are involved in processes, which maintain intracellular homeostasis. Alterations in activity, amount or distribution of protein kinase
C (PKC) isoenzymes may cause cellular proliferation or induce apoptosis. We have studied and compared the expression levels of several PKC isoforms in benign prostatic hyperplasia (BPH) and prostate cancer (PCa). These are PKCs α (alpha), β (beta), δ (delta), ε (epsilon),
ζ (zeta), η (eta), which have been detected as major isoforms in prostate tissue. Paraffin sections of 25 benign prostatic hyperplasia (BPH) and 25 of prostatic carcinoma (PCa) were examined for expression of PKC α, β, δ, ε, ζ, and η. Expression of PKC
β was examined in additional 3 BPH and 3 PCa using Western blot analysis. We found a significant high level of expression of PKC isoforms α, β, ε and η in PCa compared to BPH (p<0.01). Using backward logistic regression, we found changes in PKC ε expression to
be most significant between malignant compared to benign tumor tissue specimens. Immunostaining for PKCs α, β and η in addition to PKC ε may aid in distinguishing between benign and malignant prostatic disease.
Document Type: Research Article
Affiliations: Department of Pathology, Hasharon Hospital, Petah Tikva 49100, Israel., Email: [email protected]
Publication date: 01 February 2004
- Oncology Reports is a monthly, peer-reviewed journal devoted to the publication of high quality original studies and reviews concerning a broad and comprehensive view of fundamental and applied research in oncology, focusing on carcinogenesis, metastasis and epidemiology.
The journal is published in both print and electronic format. - Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content